{"id":5215,"date":"2025-03-07T15:09:05","date_gmt":"2025-03-07T20:09:05","guid":{"rendered":"https:\/\/scrconsultings.com\/?p=5215"},"modified":"2026-01-27T11:05:54","modified_gmt":"2026-01-27T16:05:54","slug":"ai-in-pharmacovigilance","status":"publish","type":"post","link":"https:\/\/scrconsultings.com\/es\/ai-in-pharmacovigilance\/","title":{"rendered":"La Inteligencia Artificial y el Futuro de la Farmacovigilancia"},"content":{"rendered":"<p><b><i>Q.F. Milagros Consuelo Arista Ar\u00e9valo <\/i><\/b><\/p>\n<p><b><i><\/i><\/b><strong><em>Especialista en Aseguramiento de la Calidad y Coordinadora de Farmacovigilancia y Tecnovigilancia <\/em><\/strong><strong><em>Technovigilance Coordinator<\/em><\/strong><\/p>\n<p><b><i><\/i><\/b><b><i>SCR Consultores Peru<\/i><\/b><\/p>\n<p>La farmacovigilancia es un pilar fundamental en la seguridad de los medicamentos, asegurando que sus beneficios superen cualquier riesgo potencial. En este contexto, <strong>la inteligencia artificial (IA)<\/strong> emerge como una herramienta clave que est\u00e1 transformando este campo, permitiendo una detecci\u00f3n m\u00e1s temprana de efectos adversos, una gesti\u00f3n m\u00e1s eficiente de datos y una toma de decisiones m\u00e1s precisa.<\/p>\n<h3><strong>La IA como aliada en la farmacovigilancia<\/strong><\/h3>\n<p>El uso de <strong>algoritmos de aprendizaje autom\u00e1tico y procesamiento de datos<\/strong> ha permitido a la IA mejorar significativamente la capacidad de an\u00e1lisis en farmacovigilancia. Algunas de las \u00e1reas clave donde la IA est\u00e1 impactando son:<\/p>\n<ul>\n<li><strong>Procesamiento eficiente de datos:<\/strong>La IA puede analizar grandes vol\u00famenes de datos provenientes de registros m\u00e9dicos, redes sociales, publicaciones cient\u00edficas y bases regulatorias en tiempo r\u00e9cord.<\/li>\n<li><strong>Detecci\u00f3n temprana de se\u00f1ales de seguridad:<\/strong>Los modelos predictivos permiten identificar patrones de riesgo antes de que los m\u00e9todos convencionales lo hagan, anticipando posibles reacciones adversas.<\/li>\n<li><strong>An\u00e1lisis de riesgos personalizados:<\/strong>La IA es capaz de segmentar poblaciones de pacientes con base en factores como edad, g\u00e9nero, gen\u00e9tica y condiciones m\u00e9dicas, permitiendo estrategias de mitigaci\u00f3n de riesgos m\u00e1s efectivas.<\/li>\n<li><strong>Monitoreo de redes sociales y fuentes no convencionales:<\/strong>Muchas experiencias de efectos adversos no son reportadas formalmente, pero pueden ser identificadas a trav\u00e9s del an\u00e1lisis de conversaciones en redes sociales, foros y plataformas en l\u00ednea.<\/li>\n<li><strong>Predicci\u00f3n y simulaci\u00f3n:<\/strong>Modelos avanzados pueden simular interacciones medicamentosas y prever posibles efectos secundarios antes de que un f\u00e1rmaco llegue al mercado.<\/li>\n<\/ul>\n<h3><strong>Desaf\u00edos y consideraciones \u00e9ticas<\/strong><\/h3>\n<p>A pesar de los avances, la implementaci\u00f3n de IA en farmacovigilancia enfrenta varios retos:<\/p>\n<ul>\n<li><strong>Calidad y sesgo de los datos:<\/strong>Los algoritmos dependen de la calidad de los datos con los que se entrenan. Datos sesgados pueden llevar a conclusiones err\u00f3neas.<\/li>\n<li><strong>Regulaci\u00f3n y cumplimiento normativo:<\/strong>Es fundamental que la IA cumpla con los est\u00e1ndares regulatorios y se utilice dentro de un marco \u00e9tico y transparente.<\/li>\n<li><strong>Interoperabilidad con sistemas existentes:<\/strong>La integraci\u00f3n de la IA en los sistemas actuales de farmacovigilancia puede ser compleja y requiere estrategias bien definidas.<\/li>\n<li><strong>No sustituye el juicio cl\u00ednico:<\/strong>La IA debe ser vista como una herramienta de apoyo y no como un reemplazo del criterio m\u00e9dico y regulatorio.<\/li>\n<\/ul>\n<h3><strong>El futuro de la farmacovigilancia impulsada por IA<\/strong><\/h3>\n<p>En los pr\u00f3ximos a\u00f1os, se espera una adopci\u00f3n m\u00e1s amplia de la IA en farmacovigilancia, con iniciativas como:<\/p>\n<ul>\n<li>Mayor colaboraci\u00f3n entre la industria farmac\u00e9utica, agencias regulatorias y empresas tecnol\u00f3gicas.<\/li>\n<li>Desarrollo de modelos predictivos m\u00e1s sofisticados que optimicen la seguridad de los medicamentos.<\/li>\n<li>Expansi\u00f3n del uso de IA en la toma de decisiones regulatorias para agilizar los procesos de aprobaci\u00f3n y vigilancia post-comercializaci\u00f3n.<\/li>\n<\/ul>\n<p>En conclusi\u00f3n, la inteligencia artificial est\u00e1 llamada a convertirse en un pilar central de la farmacovigilancia moderna, mejorando la seguridad de los medicamentos y respaldando a los profesionales de la salud en la toma de decisiones cr\u00edticas. En <strong>SCR Consulting<\/strong>, nos mantenemos a la vanguardia de estas innovaciones para garantizar una implementaci\u00f3n efectiva y segura de la tecnolog\u00eda en la farmacovigilancia, siempre con el objetivo de mejorar la salud p\u00fablica y la seguridad del paciente.<\/p>","protected":false},"excerpt":{"rendered":"<p>Q.F. Milagros Consuelo Arista Ar\u00e9valo QA Specialist &amp; Pharmacovigilance and Technovigilance Coordinator SCR Consulting Peru Pharmacovigilance is a fundamental pillar in drug safety, ensuring that the benefits of medications outweigh any potential risks. In this context, artificial intelligence (AI) emerges as a key tool transforming this field, enabling earlier detection of adverse effects, more efficient [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5217,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86,82,89],"tags":[],"class_list":["post-5215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-good-pharmacovigilance-practices","category-pharmaceutical-products","category-pharmacovigilance-analyst"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AI in Pharmacovigilance: Early Safety Signal Detection, Data Processing and Ethics<\/title>\n<meta name=\"description\" content=\"Explore how AI improves pharmacovigilance through faster data processing, early safety signal detection, risk stratification and monitoring of unconventional sources, plus key ethical challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/scrconsultings.com\/es\/ai-in-pharmacovigilance\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI in Pharmacovigilance: Early Safety Signal Detection, Data Processing and Ethics\" \/>\n<meta property=\"og:description\" content=\"Explore how AI improves pharmacovigilance through faster data processing, early safety signal detection, risk stratification and monitoring of unconventional sources, plus key ethical challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/scrconsultings.com\/es\/ai-in-pharmacovigilance\/\" \/>\n<meta property=\"og:site_name\" content=\"SCR Consulting\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SCRConsultings\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-07T20:09:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T16:05:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_-AI-y-Farmacovigilancia-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"402\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"SCR Insights\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"SCR Insights\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/\"},\"author\":{\"name\":\"SCR Insights\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/person\\\/459dfaf478511fd24e1cb05282a14bbd\"},\"headline\":\"Artificial Intelligence and the Future of Pharmacovigilance\",\"datePublished\":\"2025-03-07T20:09:05+00:00\",\"dateModified\":\"2026-01-27T16:05:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/\"},\"wordCount\":429,\"publisher\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_-AI-y-Farmacovigilancia-1.png\",\"articleSection\":[\"Good Pharmacovigilance Practices\",\"Pharmaceutical products\",\"Pharmacovigilance Analyst\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/\",\"name\":\"AI in Pharmacovigilance: Early Safety Signal Detection, Data Processing and Ethics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_-AI-y-Farmacovigilancia-1.png\",\"datePublished\":\"2025-03-07T20:09:05+00:00\",\"dateModified\":\"2026-01-27T16:05:54+00:00\",\"description\":\"Explore how AI improves pharmacovigilance through faster data processing, early safety signal detection, risk stratification and monitoring of unconventional sources, plus key ethical challenges.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_-AI-y-Farmacovigilancia-1.png\",\"contentUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/assets-web_-AI-y-Farmacovigilancia-1.png\",\"width\":1024,\"height\":402,\"caption\":\"Artificial Intelligence and the Future of Pharmacovigilance\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/ai-in-pharmacovigilance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/scrconsultings.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artificial Intelligence and the Future of Pharmacovigilance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/\",\"name\":\"Scr Consultings\",\"description\":\"Specialized Consulting Firm\",\"publisher\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#organization\",\"name\":\"Scr Consultings\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo-scr-consulting-592x236-1.png\",\"contentUrl\":\"https:\\\/\\\/scrconsultings.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo-scr-consulting-592x236-1.png\",\"width\":592,\"height\":236,\"caption\":\"Scr Consultings\"},\"image\":{\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/SCRConsultings\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/scr-consultings\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCbj63X1Sg-ZnCuWY4rMC5JA\\\/videos\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/scrconsultings.com\\\/es\\\/#\\\/schema\\\/person\\\/459dfaf478511fd24e1cb05282a14bbd\",\"name\":\"SCR Insights\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm\",\"caption\":\"SCR Insights\"},\"sameAs\":[\"https:\\\/\\\/scrconsultings.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AI in Pharmacovigilance: Early Safety Signal Detection, Data Processing and Ethics","description":"Explore how AI improves pharmacovigilance through faster data processing, early safety signal detection, risk stratification and monitoring of unconventional sources, plus key ethical challenges.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/scrconsultings.com\/es\/ai-in-pharmacovigilance\/","og_locale":"es_ES","og_type":"article","og_title":"AI in Pharmacovigilance: Early Safety Signal Detection, Data Processing and Ethics","og_description":"Explore how AI improves pharmacovigilance through faster data processing, early safety signal detection, risk stratification and monitoring of unconventional sources, plus key ethical challenges.","og_url":"https:\/\/scrconsultings.com\/es\/ai-in-pharmacovigilance\/","og_site_name":"SCR Consulting","article_publisher":"https:\/\/www.facebook.com\/SCRConsultings","article_published_time":"2025-03-07T20:09:05+00:00","article_modified_time":"2026-01-27T16:05:54+00:00","og_image":[{"width":1024,"height":402,"url":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_-AI-y-Farmacovigilancia-1.png","type":"image\/png"}],"author":"SCR Insights","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"SCR Insights","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#article","isPartOf":{"@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/"},"author":{"name":"SCR Insights","@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/person\/459dfaf478511fd24e1cb05282a14bbd"},"headline":"Artificial Intelligence and the Future of Pharmacovigilance","datePublished":"2025-03-07T20:09:05+00:00","dateModified":"2026-01-27T16:05:54+00:00","mainEntityOfPage":{"@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/"},"wordCount":429,"publisher":{"@id":"https:\/\/scrconsultings.com\/es\/#organization"},"image":{"@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#primaryimage"},"thumbnailUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_-AI-y-Farmacovigilancia-1.png","articleSection":["Good Pharmacovigilance Practices","Pharmaceutical products","Pharmacovigilance Analyst"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/","url":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/","name":"AI in Pharmacovigilance: Early Safety Signal Detection, Data Processing and Ethics","isPartOf":{"@id":"https:\/\/scrconsultings.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#primaryimage"},"image":{"@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#primaryimage"},"thumbnailUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_-AI-y-Farmacovigilancia-1.png","datePublished":"2025-03-07T20:09:05+00:00","dateModified":"2026-01-27T16:05:54+00:00","description":"Explore how AI improves pharmacovigilance through faster data processing, early safety signal detection, risk stratification and monitoring of unconventional sources, plus key ethical challenges.","breadcrumb":{"@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#primaryimage","url":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_-AI-y-Farmacovigilancia-1.png","contentUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2025\/03\/assets-web_-AI-y-Farmacovigilancia-1.png","width":1024,"height":402,"caption":"Artificial Intelligence and the Future of Pharmacovigilance"},{"@type":"BreadcrumbList","@id":"https:\/\/scrconsultings.com\/ai-in-pharmacovigilance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/scrconsultings.com\/"},{"@type":"ListItem","position":2,"name":"Artificial Intelligence and the Future of Pharmacovigilance"}]},{"@type":"WebSite","@id":"https:\/\/scrconsultings.com\/es\/#website","url":"https:\/\/scrconsultings.com\/es\/","name":"Scr Consultings","description":"Specialized Consulting Firm","publisher":{"@id":"https:\/\/scrconsultings.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/scrconsultings.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/scrconsultings.com\/es\/#organization","name":"Scr Consultings","url":"https:\/\/scrconsultings.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2024\/07\/logo-scr-consulting-592x236-1.png","contentUrl":"https:\/\/scrconsultings.com\/wp-content\/uploads\/2024\/07\/logo-scr-consulting-592x236-1.png","width":592,"height":236,"caption":"Scr Consultings"},"image":{"@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SCRConsultings","https:\/\/www.linkedin.com\/company\/scr-consultings\/","https:\/\/www.youtube.com\/channel\/UCbj63X1Sg-ZnCuWY4rMC5JA\/videos"]},{"@type":"Person","@id":"https:\/\/scrconsultings.com\/es\/#\/schema\/person\/459dfaf478511fd24e1cb05282a14bbd","name":"SCR Insights","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm","url":"https:\/\/secure.gravatar.com\/avatar\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f092ee73b80556a1528c8a46788da0c1bbcc70d8589685df0180151af36f9daa?s=96&d=mm","caption":"SCR Insights"},"sameAs":["https:\/\/scrconsultings.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/posts\/5215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/comments?post=5215"}],"version-history":[{"count":0,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/posts\/5215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/media\/5217"}],"wp:attachment":[{"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/media?parent=5215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/categories?post=5215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scrconsultings.com\/es\/wp-json\/wp\/v2\/tags?post=5215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}